Mergers & Acquisitions
Feb. 13, 2014
Latham guides $1.3 billion pharmaceutical sale
Firm represents San Diego-based Cadence Pharmaceuticals Inc. in its sale to Mallinckrodt plc.
Daily Journal Staff Writer
Latham & Watkins LLP advised San Diego-based Cadence Pharmaceuticals Inc. in its $1.3 billion sale to a subsidiary of Irish pharmaceutical giant Mallinckrodt PLC, which had counsel from Wachtell, Lipton, Rosen & Katz.
Per terms of the deal, announced Tuesday, Mallinckrodt will pay $14 per share in cash for Cadence, a 26 percent premium on Monday's close and 32 percent above the stock...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In